GFI SA
The score of GFI shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GFI's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 30 Jun 2023filed on 19 Jan 2024
- Year ended 30 Jun 2022filed on 12 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
GFI's financial analysis
- Solvency31.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GFI
GFI's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0456.632.349
- VAT number
- BE0456632349
- Peppol
- Registered · 0208:0456632349 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 24 Nov 1995
- Registered office
- 2811 Mechelen
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
GFI (SA) has been based in Mechelen since 1995, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 152,275 € and equity of €1.44m; its revenue is not published. Its solvency stands at 31.3%, below the median of its sector (44.2%).
Companies similar to GFI
Companies in the same business, of comparable size and area, outside its group.
- PG Pharmaceuticals Business and other management consultancy activities Opwijk · balance sheet €1.86m
- Tervest Retail sale of pharmaceutical products Tervuren · balance sheet €4.38m
- S.P.S. Retail sale of pharmaceutical products Gingelom · balance sheet €6.00m
- Gestiphar Retail sale of pharmaceutical products Charleroi · balance sheet €3.17m
- FDM Pharma Retail sale of pharmaceutical products Charleroi · balance sheet €2.84m
- Alphar Leglise Retail sale of pharmaceutical products Léglise · balance sheet €2.53m
- Pharmacie Ronlez Retail sale of pharmaceutical products Ath · balance sheet €1.96m
- Apovlam Retail sale of pharmaceutical products Ypres · balance sheet €11.0m
Frequently asked questions about GFI
What is the revenue of GFI?
GFI files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GFI?
In Belgium, the VAT number is the company number prefixed with BE: BE0456632349 for GFI, if the company is VAT-registered. Its company number (CBE) is 0456.632.349.
Where is the registered office of GFI?
According to the CBE register, the registered office of GFI is in 2811 Mechelen.
What is the equity of GFI?
At the close of the 2025 financial year, the equity of GFI amounts to 1,440,778 €, a solvency of 31.3% of total assets.
Who manages GFI?
The register lists 5 active mandates at GFI. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GFI
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →